DNX-2440 Oncolytic Adenovirus for Recurrent Glioblastoma
NCT03714334
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
16
Enrollment
OTHER
Sponsor class
Stopped
Break of stock
Conditions
Glioblastoma
Glioblastoma, Adult
Interventions
DRUG:
DNX-2440 injection
Sponsor
Clinica Universidad de Navarra, Universidad de Navarra
Collaborators
[object Object]